CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID
CB3 is a Ligand Of Interest in 2OIP designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2OIP_CB3_B_608 | 64% | 3% | 0.109 | 0.909 | 3.63 | 2.52 | 29 | 16 | 13 | 0 | 100% | 1 |
| 2OIP_CB3_C_612 | 50% | 4% | 0.138 | 0.888 | 3.1 | 2.63 | 20 | 19 | 16 | 1 | 100% | 1 |
| 2OIP_CB3_A_604 | 36% | 4% | 0.154 | 0.848 | 2.93 | 2.68 | 18 | 21 | 4 | 0 | 100% | 1 |
| 2OIP_CB3_D_616 | 31% | 10% | 0.172 | 0.843 | 2.67 | 1.65 | 21 | 13 | 8 | 0 | 100% | 1 |
| 2OIP_CB3_E_620 | 8% | 24% | 0.193 | 0.672 | 1.82 | 1.22 | 4 | 4 | 23 | 1 | 100% | 1 |
| 3DL6_CB3_C_612 | 94% | 33% | 0.03 | 0.934 | 1.35 | 1.22 | 4 | 5 | 21 | 0 | 100% | 1 |
| 3DL5_CB3_B_608 | 61% | 23% | 0.122 | 0.912 | 1.93 | 1.18 | 5 | 5 | 4 | 0 | 100% | 1 |
| 1QZF_CB3_B_608 | 29% | 19% | 0.2 | 0.861 | 2.35 | 1.04 | 8 | 2 | 5 | 1 | 100% | 1 |
| 3HJ3_CB3_A_604 | 9% | 19% | 0.212 | 0.715 | 2.43 | 0.98 | 10 | 1 | 13 | 1 | 100% | 1 |
| 6NNR_CB3_A_902 | 99% | 37% | 0.038 | 0.989 | 1.14 | 1.21 | 3 | 7 | 0 | 0 | 100% | 1 |
| 4EIL_CB3_C_702 | 99% | 23% | 0.045 | 0.986 | 1.86 | 1.27 | 7 | 5 | 5 | 0 | 100% | 1 |
| 4GEV_CB3_A_702 | 94% | 35% | 0.058 | 0.966 | 1.26 | 1.2 | 3 | 5 | 8 | 0 | 100% | 1 |
| 4ECK_CB3_A_702 | 93% | 26% | 0.074 | 0.978 | 1.41 | 1.47 | 3 | 7 | 16 | 0 | 100% | 1 |
| 2AAZ_CB3_E_2551 | 91% | 7% | 0.081 | 0.973 | 2.79 | 1.9 | 17 | 11 | 0 | 0 | 100% | 0.25 |
